UPI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an Investigation of the Board of Directors of Uroplasty, Inc....
31 Décembre 2014 - 6:33PM
Business Wire
The Law Offices of Vincent Wong are investigating potential
claims against the Board of Directors of Uroplasty, Inc.
(NasdaqCM:UPI) (“Uroplasty”) in connection with the sale of the
Company to Vision-Sciences, Inc. (NasdaqCM:VSCI).
Click here to learn about the case:
http://docs.wongesq.com/UPI-Info-Request-Form-541. There is
no cost or obligation to you.
Under the terms of the transaction, Uroplasty shareholders will
receive 3.6331 shares of Vision-Sciences for each share of
Uroplasty stock they own. The investigation concerns whether the
Board of Uroplasty breached their fiduciary duty to stockholders by
failing to adequately shop the Company before agreeing to enter
into this transaction, and whether Vision-Sciences is underpaying
for Uroplasty shares.
If you own common stock in Uroplasty and wish to obtain
additional information, please contact Vincent Wong, Esq. either
via email vw@wongesq.com, by telephone at 212.425.1140, or visit
http://docs.wongesq.com/UPI-Info-Request-Form-541.
Vincent Wong, Esq. is an experienced attorney that has
represented investors in securities litigations involving financial
fraud and violations of shareholder rights. Attorney advertising.
Prior results do not guarantee similar outcomes.
The Law Offices of Vincent WongVincent Wong, Esq.,
212-425-1140Fax. 866-699-3880vw@wongesq.com
(MM) (NASDAQ:UPI)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
(MM) (NASDAQ:UPI)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Uroplasty, Inc. (MM)